News about VDAC1 in Hypoxia.

N M Mazure1

  • 1CNRS UMR7284, INSERM U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), University of Nice, Nice, France; CNRS GDR 3697 Micronit (www.micronit.fr).

Frontiers in Oncology
|September 15, 2016
PubMed
Summary

Mitochondria in low oxygen (hypoxia) develop a truncated VDAC1 protein, enhancing cancer cell survival. Targeting this truncated VDAC1 can restore cell death sensitivity and inhibit cancer growth.

Related Concept Videos